La maladie de Parkinson en France (serveur d'exploration) - Analysis (USA)

Index « Auteurs » - entrée « Philippe Vernier »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Philippe Rostagno < Philippe Vernier < Phillip A. Low  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 7.
Ident.Authors (with country if any)Title
000700 (2004-05-07) Anita Sidhu [États-Unis] ; Christophe Wersinger [États-Unis] ; Philippe Vernier [France]alpha-Synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease.
000701 (2004-04) Christophe Wersinger [États-Unis] ; Philippe Vernier [France] ; Anita Sidhu [États-Unis]Does alpha-synuclein modulate dopaminergic synaptic content and tone at the synapse?
000702 (2004-02-10) Christophe Wersinger [États-Unis] ; Philippe Vernier [France] ; Anita Sidhu [États-Unis]Trypsin disrupts the trafficking of the human dopamine transporter by alpha-synuclein and its A30P mutant.
000712 (2004) Anita Sidhu [États-Unis] ; Christophe Wersinger [États-Unis] ; Charbel E-H. Moussa [États-Unis] ; Philippe Vernier [France]The Role of α‐Synuclein in Both Neuroprotection and Neurodegeneration
000714 (2004) Philippe Vernier [France] ; Frederic Moret [France] ; Sophie Callier [France] ; Marina Snapyan [France] ; Christophe Wersinger [États-Unis] ; Anita Sidhu [États-Unis]The Degeneration of Dopamine Neurons in Parkinson's Disease: Insights from Embryology and Evolution of the Mesostriatocortical System
000745 (2003-11) Christophe Wersinger [États-Unis] ; Delphine Prou [France] ; Philippe Vernier [France] ; Anita Sidhu [États-Unis]Modulation of dopamine transporter function by alpha-synuclein is altered by impairment of cell adhesion and by induction of oxidative stress.
000746 (2003-09) Christophe Wersinger [États-Unis] ; Delphine Prou [France] ; Philippe Vernier [France] ; Hyman B. Niznik [Canada] ; Anita Sidhu [États-Unis]Mutations in the lipid-binding domain of alpha-synuclein confer overlapping, yet distinct, functional properties in the regulation of dopamine transporter activity.

List of associated KwdEn.i

Nombre de
documents
Descripteur
2dopamine transporter
2neuroprotection
2α‐synuclein
1Animals
1Biological Evolution
1Corpus Striatum (embryology)
1Corpus Striatum (metabolism)
1Corpus Striatum (pathology)
1Disease Models, Animal
1Dopamine (metabolism)
1Humans
1MPTP
1Nerve Degeneration (etiology)
1Nerve Degeneration (metabolism)
1Nerve Degeneration (pathology)
1Parkinson Disease (complications)
1Parkinson Disease (pathology)
1Parkinson Disease (physiopathology)
1Parkinson's disease
1Parkinson's disease (PD)
1apoptosis
1development
1dopamine receptors
1neurodegeneration

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/USA/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/USA/Analysis/Author.i -k "Philippe Vernier" 
HfdIndexSelect -h $EXPLOR_AREA/Data/USA/Analysis/Author.i  \
                -Sk "Philippe Vernier" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/USA/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    USA
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Philippe Vernier
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024